CVA Family Office’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59K | Sell |
130
-11
| -8% | -$304 | ﹤0.01% | 928 |
|
|
2025
Q1 | $4K | Sell |
141
-403
| -74% | -$11.4K | ﹤0.01% | 927 |
|
|
2024
Q4 | $22.6K | Buy |
544
+537
| +7,671% | +$22.3K | ﹤0.01% | 655 |
|
|
2024
Q3 | $468 | Sell |
7
-534
| -99% | -$35.7K | ﹤0.01% | 1233 |
|
|
2024
Q2 | $64.2K | Buy |
541
+96
| +22% | +$11.4K | 0.01% | 443 |
|
|
2024
Q1 | $47.4K | Buy |
445
+315
| +242% | +$33.6K | 0.01% | 501 |
|
|
2023
Q4 | $12.9K | Buy |
+130
| New | +$12.9K | ﹤0.01% | 684 |
|
|
2023
Q3 | – | Sell |
-280
| Closed | -$34K | – | 678 |
|
|
2023
Q2 | $34K | Sell |
280
-10
| -3% | -$1.22K | 0.01% | 519 |
|
|
2023
Q1 | $44.5K | Sell |
290
-65
| -18% | -$9.98K | 0.01% | 461 |
|
|
2022
Q4 | $63.8K | Sell |
355
-40
| -10% | -$7.19K | 0.02% | 366 |
|
|
2022
Q3 | $47K | Buy |
395
+10
| +3% | +$1.19K | 0.01% | 384 |
|
|
2022
Q2 | $55K | Buy |
385
+75
| +24% | +$10.7K | 0.02% | 351 |
|
|
2022
Q1 | $53K | Buy |
310
+25
| +9% | +$4.27K | 0.01% | 386 |
|
|
2021
Q4 | $72K | Buy |
+285
| New | +$72K | 0.02% | 298 |
|
|
2021
Q1 | – | Sell |
-400
| Closed | -$42K | – | 782 |
|
|
2020
Q4 | $42K | Buy |
+400
| New | +$42K | 0.03% | 210 |
|
|
2020
Q3 | – | Sell |
-1,400
| Closed | -$90K | – | 363 |
|
|
2020
Q2 | $90K | Buy |
1,400
+400
| +40% | +$25.7K | 0.07% | 122 |
|
|
2020
Q1 | $30K | Buy |
+1,000
| New | +$30K | 0.03% | 173 |
|